All George A. Samuel III articles
-
Article
Lineage Cell Therapeutics names general counsel
Clinical-stage biotechnology company Lineage Cell Therapeutics has named George A. Samuel III as general counsel and corporate secretary.
Close menu
- Home
- About CW
-
Topics
- Back to parent navigation item
- Topics
- Accounting & Auditing
- AI
- AML
- Anti-Bribery
- Boards & Shareholders
- Culture
- ESG/Social Responsibility
- Ethics & Culture
- Europe
- Financial Services
- Internal Controls
- Regulatory Enforcement
- Regulatory Policy
- Risk Management
- Sanctions
- Surveys & Benchmarking
- Supply Chain
- Third Party Risk
- Whistleblowers
- Opinion
- Events
-
Webcasts
- Back to parent navigation item
- Webcasts
-
Upcoming webcasts
- Back to parent navigation item
- Upcoming webcasts
- May 13: Inside the Playbook: Institutional Approaches to Digital Asset Compliance
- May 20: Building A Whistleblower Program That Drives Real Outcomes
- May 22: The Compliance Practitioner Challenge: Staying Ahead of AI Regulations
- May 29: Creating TPRM Stability in an Unsettled World
- Research
- Membership
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Info
- © 2025 Compliance Week
Site powered by Webvision Cloud